Adtalem Global Education (ATGE) Stock

ATGE's second-quarter fiscal 2025 results are aided by strong enrollment growth and strategic initiatives.

Adtalem Global Education (ATGE) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.23 per share a year ago.

Adtalem (ATGE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

ATGE stock benefits from growing demand in the healthcare sector and the focus on meeting the targets set under the Growth with Purpose strategy.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

We have listed five stocks to watch as the US education sector is set for growth in 2025, driven by increasing enrollment and technological advancements.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Adtalem (ATGE) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.